Allied Telesis Holdings KK
6835
Bleach
9162
Suncall
5985
Nakayo
6715
Rise
8836
JP Stock MarketDetailed Quotes
4593 Healios KK
- 381
- +43+12.72%
20min DelayMarket Closed Feb 17 15:30 JST
37.47BMarket Cap-7.96P/E (Static)
408High335Low12.32MVolume338Open338Pre Close4.72BTurnover40852wk High34.38%Turnover Ratio98.34MShares11852wk Low-47.86EPS TTM13.65BFloat Cap2669Historical HighLossP/E (Static)35.84MShs Float114Historical Low-47.86EPS LYR21.60%Amplitude--Dividend TTM16.66P/B100Lot Size--Div YieldTTM
Healios KK News
Helios - For the fiscal year ending December 2024, significant revenue growth is expected, and research and development will be promoted in the fields of somatic stem cell regenerative Pharmaceuticals and iPSC regenerative Pharmaceuticals.
Helios <4593> announced its consolidated financial results (IFRS) for the fiscal year ending December 2024 on the 14th.
Healios KK: Correction of the interim report.
Healios KK: Financial results presentation materials for the fiscal year ending 2024/12
Healios KK: Summary of financial results for the fiscal year ending 2024/12 [IFRS] (consolidated)
Kirin HD, Matsukiyo Cocok, Dentsu Group, Rakuten Group (14th) (1379-5368)
The above Calendar is merely a schedule and is subject to change due to the company's circumstances.--------------------------------------- February 14 (Friday) <1379> Hokuto <1380> Akigawa Boku-en <1417> Mirait-Wan <142A> Jinjibu <1438> Gifu Landscaping <1443> Giken HD <1447> SAAF HD <145A> Elizbee<
Stocks that moved the day before part 2 Seer Inc, Seer Inc, Intest Corp, ETC.
Stock Name <Code> Closing Price on the 29th ⇒ Day-on-Day Change Unitika <3103> 151 -6 Short-term funds are selling off due to a sense of rebound completion. KLab <3656> 154 -8 A sense of completion may also be present in the rapid rebound. Japan Glass <5202> 383 -15 Recently, there was a rise due to a review of European production systems. Koei Tecmo <3635> 1931.5 -58.5 Iwai Cosmo Securities downgraded its investment determination. Disco <6146> 45310 +80
Stocks that moved the previous day part 2: SOFTBANK GROUP CO, Organo, Rena Science, etc.
Stock Name <Code> Closing Price on the 28th ⇒ Change from the previous day Mitsubishi Heavy Industries <7011> 2125 -159. On the 28th, there was a broad sell-off in Electrical Utilities Infrastructure related stocks. Musashi Seimitsu Industry <7220> 3015 -195, continued to show strong sell pressure in Datacenter related stocks. Fuji Electric <6504> 7564 -398, faced selling pressure as part of the Electrical Utilities Infrastructure sector. SOFTBANK GROUP CO <9984> 9176 -505, growing caution towards large-scale AI investments. Japan Mic...
The Growth 250 rebounded, supported by the rise of leading stocks in a steady development = Emerging Markets, 28th.
The Tokyo Stock Exchange Growth Market 250 Index rebounded. Although the Nikkei Average stock price fell significantly led by Semiconductor Shareholders, the impact on Emerging Markets was minor and remained strong. Major stocks such as Cover <5253.T>, Genda <9166.T>, and Free <4478.T> increased. Renascience <4889.T> and Boardluar <4413.T> saw substantial gains. Helios <4593.T> was lower. In the Standard, Sumishin SBI Net Bank <7163.T> achieved a new high. Provided by Wealth Advisor.
Helios---significant decline, discontent regarding the Financial Estimates for the fiscal year ending December 2024 and new stock issuance.
Significant decline. The previously undisclosed Financial Estimates for the fiscal year ending December 2024 have been announced. The sales revenue for the fiscal year ending December 2024 is expected to be 0.56 billion yen, which has increased compared to the previous period due to one-time income from licensing agreements related to RPE cell manufacturing methods. However, research and development expenses are projected to be 1.96 billion yen (compared to 2.304 billion yen in the previous consolidated fiscal year), and selling and general administrative expenses are estimated at 1.374 billion yen (compared to 1.184 billion yen in the same period). Operating loss is expected to be 2.843 billion yen. Additionally, a new issuance through a third-party allocation is also being considered.
Soft Front H, Shannon, and others.
＜2321＞ SoftFront H's third-party allocation for the issuance of new stocks (21.09 million 7600 shares) and the issuance of the 15th subscription rights (potential stock number 21.3 million shares, procurement amount approximately 2.071 billion yen). A business partnership has been formed with Noah Solutions, which is engaged in planning and developing solutions related to AI and quantum computing technology, to start a new business. ＜3976＞ Shannon Innovation has started discussions towards capital and business alliances with ＜3970＞. ＜4593＞ Helios has issued new stocks through third-party allocation (81.
FANUC CORP, upward revision on March 25, operating profit 152.3 billion yen ← 150.8 billion yen.
FANUC CORP ＜6954＞ announced a revision of its financial estimates for the fiscal year ending March 2025. Revenue has been revised upward from 787.8 billion yen to 791.9 billion yen, and operating profit has increased from 150.8 billion yen to 152.3 billion yen. Regarding the Factory Automation (FA) sector, the demand in the machine tool industry, which is a major customer of CNC systems, has been sluggish across the world, including domestically; however, the demand remained strong in India and China, supported by subsidy systems, leading to an increase in CNC system sales. [Positive evaluation]＜
Focus points for the PTS on the 27th = FANUC CORP, KOA, Nitto Denko ETC.
▽ FANUC CORP <6954.T>, for the cumulative total of the third quarter of the fiscal year ending March 2025 (previous year’s April-December), the consolidated operating profit was 110.5 billion yen (2.9% increase compared to the same period last year). The annual operating profit forecast has been revised upwards from 150.8 billion yen to 152.3 billion yen (7.3% increase compared to the previous period). ▽ Shannon <3976.T>, has begun discussions for capital and business collaboration with Innovation <3970.T>. ▽ KOA <6999.T>, for the cumulative total of the third quarter of the fiscal year ending March 2025 (previous year’s April-December), the consolidated operating profit was 0.56 billion yen.
Healios KK: Notice regarding publication of earnings forecasts
Healios KK: Interim report.
Emerging Markets Stock Digest: Triaires rebounds, Daiwa Cycle significantly declines.
TriEyes Inc. <4840> 317 +20 rebound. After the close of trading on the 20th, it was announced that the full-year financial estimates for the fiscal year ending December 2024 will be upwardly revised, which is seen as good news. The anticipated increase in the investment business's revenue is primarily due to the sale of new high-profit A-REIT ETF properties, and the cost rate of the Construction consulting business has improved compared to forecasts. As a result, the group's overall revenue is expected to slightly increase from 0.942 billion yen to 0.961 billion yen, while operating profit is expected to rise by 0.06 billion yen.
Hot Stocks Digest (Morning Session): SWCC, Sumitomo Pharma, Helios, ETC.
MAZDA MOTOR CRP <7261>: 988.1 yen (-36.4 yen) shows a significant decline after struggling to gain ground. As President Trump is being inaugurated, there was an initial sense of security regarding buying due to reports of tariff postponement. However, it was later stated that he is considering imposing a 25% tariff as a countermeasure against the inflow of illegal immigrants and illegal drugs from Canada and Mexico, and he believes it will be implemented on February 1, leading to a shift toward a sell-dominant situation. Additionally, the company is exporting to the U.S. from Mexico.
Helios --- fell back, entered into a joint business agreement and a Single Option license agreement with Akatsuki.
It fell back. It was announced that a joint business contract and a Single Option license agreement were concluded with Akatsuki, a 100% owned subsidiary, to promote research and development of next-generation cancer immunotherapy using eNK cells. Although it started rising, the upper price was heavy. Moving forward, Akatsuki will lead the research and development operations for eNK cells that have been conducted independently, and the company will be commissioned by Akatsuki. This is expected to reduce the burden of research and development funding, with initial commissioning from Akatsuki anticipated by February 2025.
Healios Teams Up With Akatsuki for ENK Cell Cancer Therapies
Stocks that moved the previous day part 2: Metaplanet, Yamagata University, Ikuyo ETC.
Stock Name <Code> 20-day closing price ⇒ Compared to the previous day. BEIKARENT <6532> 5758 -134; a calm after the price increase following the Earnings Reports. NEXELAPHARMA <4565> 979 -19; profit-taking by short-term funds after last weekend's rapid surge. KIOXIA HD <285A> 1708 -80; caution against some tabloid reports. CELES <3696> 3035 -60; seen as a supply-demand factor, but among Cryptos-related stocks, the resistance at higher levels is noticeable. NINTENDO CO LTD <7974> 8901 -280; MOL.
Helios, Symbio Pharmaceutical and others.
＜3777＞ A new environmentally friendly business will be launched through a third-party allocation of new Shares (10 million shares) and the issuance of the 22nd subscription rights (potential number of shares 20 million shares, raised amount approximately 0.572 billion yen). ＜4582＞ The 5th issuance of unsecured Convertible Bonds with subscription rights by SynBio Pharmaceuticals (potential number of shares 3.5 million shares, raised amount approximately 0.6 billion yen). ＜4593＞ Joint business contract and Single Option with Akatsuki involved in the research, development, manufacturing, and sales of Helios Pharmaceuticals.